KRMD Stock — Repro Med Systems Inc

Repro Med Systems Inc (KRMD)

Updated October 16, 2026.

KRMD is a Stock. Total return is 255.5% over the past 39.5 years.

KORU Medical Systems, Inc. develops and commercializes subcutaneous infusion delivery systems designed to administer therapies for chronic illnesses including immunodeficiency disorders and blood disorders. The company manufactures syringe drivers, safety needle sets, and related equipment primarily for the U.S. market. The company does not currently have an established distribution schedule.

KRMD performance

Price and return data through 2026-10-16.

Total return is 255.5% over the past 39.5 years. Over the past year its total return — price change plus distributions reinvested — is -25.4%. Its deepest 1-year drawdown was 55.1%.

KRMD key facts

Asset type

Stock

Asset class

Equity

Inception date

04/27/1987

Distribution frequency

None

Last close

$3.00 (as of 2026-10-16)

Market cap

$137,799,000

Average volume

165230.0

Beta

0.386

Payout ratio

0.0%

Forward P/E

81.9672

EPS

$-0.04

How Dividend Vision calculates yield and returns

Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.

Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology

Sources and review

Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

KRMD risks and drawbacks

The deepest 1-year drawdown on record here is 55.1%.

Who may consider KRMD — and who may not

It is a weaker fit for investors who need monthly cash flow (KRMD does not currently distribute). This is educational context, not a recommendation to buy or sell.

More on KRMD

• All tickers starting with K

Tagged: Healthcare.

Frequently asked questions